Dapagliflozin with continuous glucose monitoring for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a diabetes medication called dapagliflozin works better when paired with continuous glucose monitoring (a sensor that checks blood sugar all day) compared to finger-stick blood tests. The goal is to help you control your blood sugar more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–60 years old
- Recently diagnosed with type 2 diabetes (within 5 years) and not on other diabetes medications in the past 3 months
- Blood sugar control level (HbA1c) between 7% and 9%
- Able to use a smartphone, glucose monitor, smart scale, and smartwatch with training
- Willing to keep your diet and exercise habits stable during the study
- Can provide at least 70% of data from the glucose monitor during the trial run-in period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a special monitoring system can help people with type 1 diabetes use SGLT2i medications safely, alongside insulin and a continuous glucose monitor.
This study tests whether using a continuous glucose monitor (CGM) helps people who were just diagnosed with type 2 diabetes manage their blood sugar better. Participants wear a small sensor on their arm that checks sugar levels all the time.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.